AB SCIENCE PATENT FOR MASITINIB IN THE TREATMENT OF SICKLE CELL DISEASE FORMALLY GRANTED IN THE UNITED STATES WITH A PROTECTION UNTIL 2040 THIS DECISION STRENGTHENS MASITINIB’S INTELLECTUAL PROPERTY ...
DENVER, May 31, 2022 /PRNewswire/ -- CryoMass Technologies Inc. (CRYM) ("CryoMass" or the "Company") (OTC: CRYM) is pleased to announce that the Canadian Intellectual Property Office has granted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback